Intellia Therapeutics
NTLA
NTLA
76 hedge funds and large institutions have $236M invested in Intellia Therapeutics in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 11 closing their positions.
Holders
76
Holders Change
+6
Holders Change %
+8.57%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
19
Reduced
18
Closed
11
Calls
$478K
Puts
$599K
Net Calls
-$121K
Net Calls Change
-$121K
Top Buyers
1 |
1
BlackRock
New York
|
$13.3M |
2 |
GC
2
GMT Capital
Atlanta,
Georgia
|
$4.66M |
3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$1.36M |
4 |
PC
4
Paulson & Co
New York
|
$1.11M |
5 |
AIM
5
ARK Investment Management
St. Petersburg,
Florida
|
$1.13M |